Optigenex Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPGX research report →
Companywww.optigenex.com
Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
- CEO
- Daniel Zwiren
- IPO
- 2012
- HQ
- Melissa, TX, US
Price Chart
Valuation
- Market Cap
- $17
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -7.53
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -22.10%
- Op Margin
- 298.48%
- Net Margin
- -621.88%
- ROE
- 46.25%
- ROIC
- 44.10%
Growth & Income
- Revenue
- $465.97K · 54.85%
- Net Income
- $-2,897,760 · 60.61%
- EPS
- $0.00 · 0.00%
- Op Income
- $1.39M
- FCF YoY
- 84.44%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 9.18
- Avg Volume
- 16
Get TickerSpark's AI analysis on OPGX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OPGX Coverage
We haven't published any research on OPGX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OPGX Report →